Stockholders' Equity (Details) - USD ($) |
1 Months Ended | 3 Months Ended | 9 Months Ended | 12 Months Ended | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 13, 2021 |
Aug. 05, 2021 |
Jun. 11, 2021 |
May 01, 2021 |
Jan. 19, 2021 |
Dec. 08, 2020 |
Nov. 03, 2020 |
Aug. 14, 2020 |
Jun. 03, 2020 |
Feb. 15, 2021 |
Jan. 25, 2021 |
Sep. 30, 2021 |
Jun. 30, 2021 |
Mar. 31, 2021 |
Sep. 30, 2020 |
Sep. 30, 2021 |
Sep. 30, 2020 |
Dec. 31, 2020 |
Dec. 31, 2018 |
Jun. 08, 2021 |
Apr. 13, 2021 |
Mar. 28, 2021 |
Jan. 29, 2021 |
Nov. 12, 2020 |
Sep. 30, 2018 |
|
| Stockholders' Equity (Details) [Line Items] | |||||||||||||||||||||||||
| Preferred stock, authorized | 5,000,000 | 5,000,000 | 10,000,000 | ||||||||||||||||||||||
| Preferred stock, par value (in Dollars per share) | $ 0.0001 | $ 0.0001 | $ 0.0001 | ||||||||||||||||||||||
| Preferred shares designated | 5,000,000 | 5,000,000 | |||||||||||||||||||||||
| Certificate of designate series A preferred stock | 5,000,000 | ||||||||||||||||||||||||
| Conversion trigger, percentage | 25.00% | ||||||||||||||||||||||||
| Conversion trigger, per share (in Dollars per share) | $ 6 | ||||||||||||||||||||||||
| Effective interest rate | 25.00% | 25.00% | |||||||||||||||||||||||
| Effective conversion price (in Dollars) | $ 6 | $ 6 | |||||||||||||||||||||||
| Preferred stock, shares outstanding | |||||||||||||||||||||||||
| Aggregate of shares | 8,142,894 | ||||||||||||||||||||||||
| Common stock, authorized | 116,666,667 | 116,666,667 | 116,666,667 | ||||||||||||||||||||||
| Common stock, par value (in Dollars per share) | $ 0.0001 | $ 0.0001 | $ 0.0001 | ||||||||||||||||||||||
| Common stock, shares issued | 40,788,681 | 40,788,681 | 26,540,769 | ||||||||||||||||||||||
| Shares issued | 7,360,000 | 6,400,000 | 116,666,667 | ||||||||||||||||||||||
| Purchase additional shares | 960,000 | ||||||||||||||||||||||||
| Common stock public price (in Dollars per share) | $ 6.51 | ||||||||||||||||||||||||
| Public price (in Dollars per share) | $ 7 | ||||||||||||||||||||||||
| Underwriter expenses (in Dollars) | $ 47,523,569 | ||||||||||||||||||||||||
| Reverse stock split, description | On November 3, 2020, the Board of Directors of the Company approved a one-for-three reverse stock split of the Company’s authorized and outstanding common stock, effective November 13, 2020 (the “Reverse Stock Split”). | ||||||||||||||||||||||||
| Capital value (in Dollars) | $ 150,000,000 | ||||||||||||||||||||||||
| Number of warrants to purchase of common stock | 6,667 | 131,271 | |||||||||||||||||||||||
| Weighted-average contractual remaining life | 5 years 6 months | ||||||||||||||||||||||||
| Exercise price (in Dollars per share) | $ 9.75 | $ 9.75 | $ 8.72 | ||||||||||||||||||||||
| Warrants value (in Dollars) | $ 65,003 | $ 1,279,892 | |||||||||||||||||||||||
| Common stock reserved for issuance | 50,000 | ||||||||||||||||||||||||
| Stock options to purchase of common stock | 879,044 | 643,006 | 593,006 | 879,044 | 568,006 | ||||||||||||||||||||
| Stock options exercise price (in Dollars per share) | $ 6.39 | $ 7.03 | $ 7.63 | $ 6.39 | $ 7.39 | ||||||||||||||||||||
| Fair value per share (in Dollars per share) | $ 2.64 | ||||||||||||||||||||||||
| Purchase of additional stock options | 25,000 | ||||||||||||||||||||||||
| Stock option of exercise price (in Dollars per share) | $ 8.72 | ||||||||||||||||||||||||
| Stock option of grant fair value of per share (in Dollars per share) | $ 2.37 | ||||||||||||||||||||||||
| Description of granted stock options | the Company granted stock options to purchase 211,038 shares of common stock, of which 59,543 options were immediately vested and the remaining 151,495 vest monthly through August 4, 2025. The vested ten-year options have an exercise price ranging from $1.37 to 2.09 per share and a grant date fair value ranging from $5.69 to $6.41 per share. The unvested ten-year options have an exercise price of $2.09 and a grant date fair value of $5.94 a share. | ||||||||||||||||||||||||
| Stock compensation expense (in Dollars) | $ 536,797 | $ 81,174 | |||||||||||||||||||||||
| Share based compensation (in Dollars) | $ 824,315 | $ 833,959 | |||||||||||||||||||||||
| Stock-based compensation (in Dollars) | 0 | $ 10,117 | |||||||||||||||||||||||
| Compensation, description | the Compensation Committee approved the following grants: (a) for Messrs. Cohen, Reisfield and Silverman (i) 5,000 restricted stock units pursuant to the 2018 Plan, and (b) for Mr. Seidl and Ms. Sood (i) 5,000 restricted stock units pursuant to the 2018 Plan, and (ii) 10,000 restricted stock units pursuant to the 2018 Plan. Each restricted stock unit represents a contingent right to receive one share of common stock of the Company. The 5,000 restricted stock units granted to each of Messrs. Cohen, Reisfield, Silverman and Seidl and Ms. Sood vest in four successive equal quarterly installments with the first vesting date commencing on the first day of the next calendar quarter, provided that such director is a director of the Company on the applicable vesting dates. The 10,000 restricted stock units granted to Mr. Seidl and Ms. Sood vest in eight successive equal quarterly installments with the first vesting date commencing on the first day of the next calendar quarter, provided that such director is a director of the Company on the applicable vesting dates. All restricted stock units granted to these directors shall vest in full immediately upon a change in control. The company recognized stock-based compensation of $111,300 and $333,900 for the three and nine months ended September 30, 2021. As of September 30, 2021, the unrecognized compensation expense was $238,500.On August 5, 2021, the Company entered into employment agreements and awarded 1,375,000 restricted stock units pursuant to the 2018 Plan to key members of American Robotics’ management. Each restricted stock unit represents a contingent right to receive one share of common stock of the Company. | ||||||||||||||||||||||||
| Restricted stock unit (in Dollars) | $ 1,375,000 | ||||||||||||||||||||||||
| Unrecognized compensation of expenses (in Dollars) | $ 10,697,500 | ||||||||||||||||||||||||
| Stock Options [Member] | |||||||||||||||||||||||||
| Stockholders' Equity (Details) [Line Items] | |||||||||||||||||||||||||
| Stock options to purchase of common stock | 25,000 | 90,000 | |||||||||||||||||||||||
| Stock-based compensation expense (in Dollars) | $ 514,866 | ||||||||||||||||||||||||
| Options term | 10 years | 10 years | |||||||||||||||||||||||
| Stock options exercise price (in Dollars per share) | $ 12.92 | $ 12.72 | |||||||||||||||||||||||
| Weighted average grant-date fair value (in Dollars per share) | $ 5.82 | $ 5.72 | |||||||||||||||||||||||
| Unrecognized compensation expense (in Dollars) | 989,000 | $ 989,000 | |||||||||||||||||||||||
| Weighted-average contractual remaining life | 1 year 9 months 18 days | ||||||||||||||||||||||||
| Restricted Stock Units (RSUs) [Member] | |||||||||||||||||||||||||
| Stockholders' Equity (Details) [Line Items] | |||||||||||||||||||||||||
| Weighted-average contractual remaining life | 1 year 3 months | ||||||||||||||||||||||||
| Weighted average grant-date fair value (in Dollars per share) | $ 0.64 | ||||||||||||||||||||||||
| Unrecognized compensation expense (in Dollars) | $ 5,250,000 | ||||||||||||||||||||||||
| Stock compensation expense (in Dollars) | $ 3,150,000 | ||||||||||||||||||||||||
| Restricted stock purchase | 1,000,000 | 126,160 | |||||||||||||||||||||||
| Weighted average grant-date fair value of exercise price (in Dollars per share) | $ 8.4 | ||||||||||||||||||||||||
| Vesting period | 2 years | 2 years | |||||||||||||||||||||||
| Restricted Stock Units (RSUs) [Member] | Thomas V. Bushey [Member] | |||||||||||||||||||||||||
| Stockholders' Equity (Details) [Line Items] | |||||||||||||||||||||||||
| Description of restricted stock units | Effective January 19, 2021, (i) Mr. Bushey received 500,000 RSU Shares (375,000 RSU Shares vested as of December 31, 2020 and 125,000 RSU Shares on which the Compensation Committee accelerated vesting), which RSU Shares will be issued on June 3, 2022 pursuant to Mr. Bushey’s deferral election, and (ii) 500,000 RSU shares were canceled. | ||||||||||||||||||||||||
| Consultant [Member] | Restricted Stock Units (RSUs) [Member] | |||||||||||||||||||||||||
| Stockholders' Equity (Details) [Line Items] | |||||||||||||||||||||||||
| Stock compensation expense (in Dollars) | $ 0 | $ 30,357 | |||||||||||||||||||||||
| Director [Member] | |||||||||||||||||||||||||
| Stockholders' Equity (Details) [Line Items] | |||||||||||||||||||||||||
| Stock compensation expense (in Dollars) | 270,000 | ||||||||||||||||||||||||
| Recognized stock based compensation (in Dollars) | $ 0 | $ 90,000 | |||||||||||||||||||||||
| Director [Member] | Restricted Stock Units (RSUs) [Member] | |||||||||||||||||||||||||
| Stockholders' Equity (Details) [Line Items] | |||||||||||||||||||||||||
| Stock Issued During Period, Value, Restricted Stock Award, Forfeitures (in Dollars) | $ 60,000 | ||||||||||||||||||||||||
| Convertible Preferred Stock [Member] | |||||||||||||||||||||||||
| Stockholders' Equity (Details) [Line Items] | |||||||||||||||||||||||||
| Conversion trigger, percentage | 25.00% | ||||||||||||||||||||||||
| Preferred stock, shares outstanding | 2,350,390 | ||||||||||||||||||||||||
| Conversion of aggregate of shares | 979,361 | ||||||||||||||||||||||||
| Aggregate of shares | 195,881 | ||||||||||||||||||||||||
| Dividend of shares | 15,093 | ||||||||||||||||||||||||
| Common Stock [Member] | |||||||||||||||||||||||||
| Stockholders' Equity (Details) [Line Items] | |||||||||||||||||||||||||
| Common stock, authorized | 116,666,667 | 116,666,667 | |||||||||||||||||||||||
| Common stock, par value (in Dollars per share) | $ 0.0001 | $ 0.0001 | |||||||||||||||||||||||
| Common stock, shares issued | 40,788,681 | 40,788,681 | |||||||||||||||||||||||
| Series A Convertible Preferred Stock [Member] | |||||||||||||||||||||||||
| Stockholders' Equity (Details) [Line Items] | |||||||||||||||||||||||||
| Preferred stock, authorized | 5,000,000 | 5,000,000 | 5,000,000 | ||||||||||||||||||||||
| Preferred stock, par value (in Dollars per share) | $ 0.0001 | $ 0.0001 | $ 0.0001 | ||||||||||||||||||||||
| Preferred shares designated | 5,000,000 | 5,000,000 | |||||||||||||||||||||||
| Preferred stock, shares outstanding | |||||||||||||||||||||||||
| Common Stock [Member] | |||||||||||||||||||||||||
| Stockholders' Equity (Details) [Line Items] | |||||||||||||||||||||||||
| Transfer or dispose | 2,583,826 | ||||||||||||||||||||||||
| Shares issued | 2,583,826 | 2,583,826 | |||||||||||||||||||||||
| 2018 Equity Incentive Plan [Member] | |||||||||||||||||||||||||
| Stockholders' Equity (Details) [Line Items] | |||||||||||||||||||||||||
| Common stock reserved for issuance | 3,333,334 | ||||||||||||||||||||||||
| Preferred Stock [Member] | |||||||||||||||||||||||||
| Stockholders' Equity (Details) [Line Items] | |||||||||||||||||||||||||
| Preferred stock, authorized | 10,000,000 | 10,000,000 | |||||||||||||||||||||||
| Preferred stock, par value (in Dollars per share) | $ 0.0001 | $ 0.0001 | |||||||||||||||||||||||
| Transfer or dispose | |||||||||||||||||||||||||
| Warrant [Member] | |||||||||||||||||||||||||
| Stockholders' Equity (Details) [Line Items] | |||||||||||||||||||||||||
| Purchase of warrants | 1,565,656 | 1,565,656 | |||||||||||||||||||||||
| Warrant exercise price (in Dollars per share) | $ 7.89 | ||||||||||||||||||||||||
| Purchase aggregate description | During the nine months ended September 30, 2020, the Company’s Board issued (i) Warrants to purchase an aggregate of 279,460 shares of Common Stock with an exercise price of $7.50 per share and (ii) Warrants to purchase an aggregate of 9,793 shares of Common Stock with an exercise price of $6.39 per share. | ||||||||||||||||||||||||
| Number of warrants to purchase of common stock | 3,307,521 | 3,307,521 | |||||||||||||||||||||||
| Warrants exercise price (in Dollars per share) | $ 8.53 | $ 8.53 | |||||||||||||||||||||||
| Warrant [Member] | Minimum [Member] | |||||||||||||||||||||||||
| Stockholders' Equity (Details) [Line Items] | |||||||||||||||||||||||||
| Warrants exercise price (in Dollars per share) | 0.03 | 0.03 | |||||||||||||||||||||||
| Warrant [Member] | Maximum [Member] | |||||||||||||||||||||||||
| Stockholders' Equity (Details) [Line Items] | |||||||||||||||||||||||||
| Warrants exercise price (in Dollars per share) | $ 9.75 | $ 9.75 | |||||||||||||||||||||||